Publication: Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis.
Loading...
Identifiers
Date
2022-05-09
Authors
García-Fortes, María
Hernández-Boluda, Juan C
Álvarez-Larrán, Alberto
Raya, José M
Angona, Anna
Estrada, Natalia
Fox, Laura
Cuevas, Beatriz
García-Hernández, María C
Gómez-Casares, María Teresa
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
The comorbidity burden is an important risk factor for overall survival (OS) in several hematological malignancies. This observational prospective study was conducted to evaluate the impact of individual comorbidities on survival in a multicenter series of 668 patients with primary myelofibrosis (PMF) or MF secondary to polycythemia vera (PPV-MF) or essential thrombocythemia (PET-MF). Hypertension (hazard ratio (HR) = 4.96, p
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
comorbidities, myelofibrosis, prognosis, survival